DARK Classics in Chemical Neuroscience: Etonitazene and Related Benzimidazoles
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DARK Classics in Chemical Neuroscience: Etonitazene and Related Benzimidazoles
Authors
Keywords
-
Journal
ACS Chemical Neuroscience
Volume 12, Issue 7, Pages 1072-1092
Publisher
American Chemical Society (ACS)
Online
2021-03-25
DOI
10.1021/acschemneuro.1c00037
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Isotonitazene: Fatal intoxication in three cases involving this unreported novel psychoactive substance in Switzerland
- (2021) F. Mueller et al. FORENSIC SCIENCE INTERNATIONAL
- Synthesis, Chemical Characterization, and μ-Opioid Receptor Activity Assessment of the Emerging Group of “Nitazene” 2-Benzylbenzimidazole Synthetic Opioids
- (2021) Marthe M. Vandeputte et al. ACS Chemical Neuroscience
- Isotonitazene Quantitation and Metabolite Discovery in Authentic Forensic Casework
- (2020) Alex J Krotulski et al. JOURNAL OF ANALYTICAL TOXICOLOGY
- Safety benefits of ‘biased’ opioids scrutinized
- (2020) Kelly Servick SCIENCE
- DARK Classics in Chemical Neuroscience: U-47700
- (2020) Kwaku Kyei-Baffour et al. ACS Chemical Neuroscience
- DARK Classics in Chemical Neuroscience: Heroin and Desomorphine
- (2020) Jaime Mella-Raipán et al. ACS Chemical Neuroscience
- DARK Classics in Chemical Neuroscience: Carfentanil
- (2020) Anna E Ringuette et al. ACS Chemical Neuroscience
- In vitro functional characterization of a panel of non-fentanyl opioid new psychoactive substances
- (2020) Marthe M. Vandeputte et al. ARCHIVES OF TOXICOLOGY
- First report on brorphine: the next opioid on the deadly new psychoactive substances’ horizon?
- (2020) Nick Verougstraete et al. JOURNAL OF ANALYTICAL TOXICOLOGY
- Atomic-Level Characterization of the Methadone-Stabilized Active Conformation of µ-Opioid Receptor
- (2020) Abhijeet Kapoor et al. MOLECULAR PHARMACOLOGY
- Intrinsic efficacy of opioid ligands and its importance for apparent bias, operational analysis and therapeutic window
- (2020) Alexander Gillis et al. MOLECULAR PHARMACOLOGY
- Post-translational Modifications of Opioid Receptors
- (2020) Mariana Lemos Duarte et al. TRENDS IN NEUROSCIENCES
- DARK Classics in Chemical Neuroscience: Krokodil
- (2020) Emanuele Amorim Alves ACS Chemical Neuroscience
- Etazene (N,N-diethyl-2-{[(4-ethoxyphenyl)methyl]-1H-benzimidazol-1-yl}-ethan-1-amine (dihydrochloride)): a novel benzimidazole opioid NPS identified in seized material: crystal structure and spectroscopic characterization
- (2020) Marta Siczek et al. Forensic Toxicology
- Biased Opioid Ligands
- (2020) Abdelfattah Faouzi et al. MOLECULES
- Biased versus Partial Agonism in the Search for Safer Opioid Analgesics
- (2020) Joaquim Azevedo Neto et al. MOLECULES
- Emerging Characteristics of Isotonitazene-Involved Overdose Deaths
- (2020) Chelsea L. Shover et al. Journal of Addiction Medicine
- Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex
- (2019) Kaavya Krishna Kumar et al. CELL
- Molecular basis of opioid action: from structures to new leads
- (2019) Aashish Manglik BIOLOGICAL PSYCHIATRY
- Report on a novel emerging class of highly potent benzimidazole NPS opioids: chemical and in vitro functional characterization of isotonitazene
- (2019) Peter Blanckaert et al. Drug Testing and Analysis
- Benzimidazole: A milestone in the field of medicinal chemistry
- (2019) Mahesh S. Vasava et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Toward a Universal μ-Agonist Template for Template-Based Alignment Modeling of Opioid Ligands
- (2019) Zhijun Wu et al. ACS Omega
- Toward Directing Opioid Receptor Signaling to Refine Opioid Therapeutics
- (2019) Travis W. Grim et al. BIOLOGICAL PSYCHIATRY
- DARK Classics in Chemical Neuroscience: Fentanyl
- (2018) S. Mallory Burns et al. ACS Chemical Neuroscience
- DARK Classics in Chemical Neuroscience: Morphine
- (2018) Andrea L. Devereaux et al. ACS Chemical Neuroscience
- Structure–Activity Relationships and Computational Investigations into the Development of Potent and Balanced Dual-Acting Butyrylcholinesterase Inhibitors and Human Cannabinoid Receptor 2 Ligands with Pro-Cognitive in Vivo Profiles
- (2018) Dominik Dolles et al. JOURNAL OF MEDICINAL CHEMISTRY
- Predicting opioid receptor binding affinity of pharmacologically unclassified designer substances using molecular docking
- (2018) Christopher R. Ellis et al. PLoS One
- DARK Classics in Chemical Neuroscience: Opium, a historical perspective
- (2018) Christopher Presley et al. ACS Chemical Neuroscience
- Optimization of a Series of Mu Opioid Receptor (MOR) Agonists with High G Protein Signaling Bias
- (2018) Nicole M. Kennedy et al. JOURNAL OF MEDICINAL CHEMISTRY
- DARK Classics in Chemical Neuroscience: Opium, a Friend or Foe
- (2018) Parvez Alam et al. ACS Chemical Neuroscience
- Investigating the Antidepressant-like Effects of some Benzimidazolepiperidine Derivatives by In-Vivo Experimental Methods
- (2018) Nazlı Turan et al. Letters in Drug Design & Discovery
- Therapeutic evolution of benzimidazole derivatives in the last quinquennial period
- (2017) Wasim Akhtar et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Chemometrics-assisted chromatographic fingerprinting: An illicit methamphetamine case study
- (2017) Nafiseh Shekari et al. JOURNAL OF SEPARATION SCIENCE
- Synthesis and antinociceptive activities of some novel benzimidazole-piperidine derivatives
- (2017) Ümide DEMİR ÖZKAY et al. TURKISH JOURNAL OF CHEMISTRY
- Opioid Receptors
- (2016) Christoph Stein Annual Review of Medicine
- Could chest wall rigidity be a factor in rapid death from illicit fentanyl abuse?
- (2016) Glenn Burns et al. CLINICAL TOXICOLOGY
- Phosphoproteomic analysis of the mouse brain mu-opioid (MOP) receptor
- (2015) Lionel Moulédous et al. FEBS LETTERS
- Development of drugs based on imidazole and benzimidazole bioactive heterocycles: recent advances and future directions
- (2015) Monika Gaba et al. MEDICINAL CHEMISTRY RESEARCH
- NOpiates: Novel Dual Action Neuronal Nitric Oxide Synthase Inhibitors with μ-Opioid Agonist Activity
- (2012) Paul Renton et al. ACS Medicinal Chemistry Letters
- Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery
- (2011) Arup K. Ghose et al. ACS Chemical Neuroscience
- Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to human
- (2011) Michael M Morgan et al. BRITISH JOURNAL OF PHARMACOLOGY
- Consensus 3D Model of μ-Opioid Receptor Ligand Efficacy Based on a Quantitative Conformationally Sampled Pharmacophore
- (2011) Jihyun Shim et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Benzimidazole Derivatives as New Serotonin 5-HT6Receptor Antagonists. Molecular Mechanisms of Receptor Inactivation
- (2010) Tania de la Fuente et al. JOURNAL OF MEDICINAL CHEMISTRY
- Analysis of the opioid–opioid combinations according to the nociceptive stimulus in mice
- (2010) Asunción Romero et al. PHARMACOLOGICAL RESEARCH
- Intravenous self-administration of etonitazene alone and combined with cocaine in rhesus monkeys: comparison with heroin and antagonism by naltrexone and naloxonazine
- (2009) Cindy Achat-Mendes et al. PSYCHOPHARMACOLOGY
- Novel benzimidazole derivatives as selective CB2 agonists
- (2008) Daniel Pagé et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started